Receiving a cancer diagnosis is a life-changing event, and the path through treatment can be among the hardest things a person goes through in life. Survivors can face a variety of physical and emotional effects, both during and after their treatment that can significantly lower their quality of life.
There are many options available to help patients cope with these effects, including spiritual support, counseling...
An innovative new technology is now providing radiation oncologists at MD Anderson Cancer Center a real-time view of tumors while they use...
In recent years, the surgical technique sentinel lymph node biopsy has allowed surgeons to more accurately determine how far cancer has spread...
Lymphomas are the most common hematological malignancy in the U.S.,
accounting for an estimated 80,000 new cancer diagnoses and 21,000
deaths each year. These cancers, broadly classified as either Hodgkin
lymphomas or non-Hodgkin lymphomas, develop in the lymphatic system.
Approximately 85 percent of cases are B-cell lymphomas, meaning they
arise in B lymphocytes.
MD Anderson’s B-Cell Lymphoma Moon Shot™ is working toward...
As his first official act of Nobel Week, 2018 Nobel Laureate in Physiology or Medicine Jim Allison, Ph.D., on Thursday signed the bottom of...
It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is a cornerstone...
Researchers in MD Anderson’s Leukemia department played central roles in the studies of two drugs, glasdegib and venetoclax, approved in November...
Despite a plethora of new and promising treatments available, lung cancer remains the leading cause of cancer death in the United States,...
Pancreatic cancer is one of the most lethal types of cancer, expected to cause more than 44,000 deaths in the U.S. this year. It’s a deadly...
MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to rapidly advance...